Skip to content
Menu

Instil Bio, Inc. TIL

Full chart Compare
Set alert

Price alert · TIL

All alert types
5.55 USD +0.12 (+2.21%)

Regular-session close

5.55 0.00 0.00%

After hours · Nov 19, 4:00 PM ET

5.49 Day range 5.77
5.14 52-week range 13.50
YTD
-49.55%
1 year
-54.51%

 

No chart data for this range yet.
Market cap
37.64M
EPS (ttm)
-3.09
Shares out
6.53M
Forward P/E
-1.80
YTD return
-49.55%
1-year return
-54.51%
50-day average
29.13
200-day average
20.96
Enterprise value
128.32M
Volume
61.88K
Avg volume
40.24K
Open
5.55
Previous close
5.43
Day's range
5.49 – 5.77
52-week range
5.14 – 13.50
Beta
1.74
Analysts
Buy
Price target
100.33 (+1707.8%)

Key statistics

Price / book
0.63
Free cash flow
-27.20M
Total cash
148.77M
Total debt
85.61M
Return on equity
-48.65%
Short % of float
10.03%

Fundamental scorecard

4 of 25 checks passed on TIL’s reported financials

ValueGrowthProfitabilityHealthDividend

4of 25 checks passed

  • Value 1 of 5
  • Growth 1 of 5
  • Profitability 0 of 5
  • Financial health 2 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
TIL Revenue — quarterly 0
TIL Net income — quarterly -4.23M
TIL EPS — quarterly -0.62

Earnings

TIL recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 13, 2024Sep 1, 2024-2.08-3.54-1.46-70.19%
Aug 13, 2024Jun 1, 2024-3.04-2.29+0.75+24.67%
Aug 13, 2024Jun 1, 2024-3.04———
May 10, 2024Mar 1, 2024-2.16———
May 10, 2024Mar 1, 2024-2.16-3.74-1.58-73.15%
Mar 21, 2024Dec 1, 20230.00-1.99——

Upgrades / downgrades

TIL analyst upgrades and downgrades
DateFirmActionFromTo
Nov 18, 2024HC Wainwright & Co.reitBuyBuy
Nov 14, 2024HC Wainwright & Co.mainBuyBuy
Nov 4, 2024JMP Securitiesinit—Market Perform
Sep 17, 2024HC Wainwright & Co.reitBuyBuy
Sep 16, 2024HC Wainwright & Co.mainBuyBuy
Sep 16, 2024BairdreitOutperformOutperform

About Instil Bio, Inc.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on TIL — it syncs with the Stock Master app.

Institution ownership

TIL institution ownership
Holder% heldSharesValueReported
Curative Ventures V LLC29.10%1,899,00441.25MSep 29, 2024
Vivo Capital, LLC9.57%624,33913.56MSep 29, 2024
CPMG INC6.30%410,9228.93MSep 29, 2024
Boxer Capital, LLC5.45%355,5007.72MSep 29, 2024
Perceptive Advisors Llc5.29%345,5457.51MSep 29, 2024
BML Capital Management, LLC5.13%335,0007.28MSep 29, 2024

Fund ownership

TIL fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.32%85,9031.87MSep 29, 2024
Invesco Main Street Small Cap Fund1.04%67,7741.47MSep 29, 2024
Vanguard Extended Market Index Fund0.93%60,7551.32MSep 29, 2024
Invesco V.I. Main Street Small Cap Fund0.48%31,570685.70KSep 29, 2024
Fidelity Extended Market Index Fund0.33%21,762472.67KOct 30, 2024
Massmutual Premier Small Cap Opportunities Fund0.22%14,439313.62KSep 29, 2024